Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
|
|
28.
|
|
|
29.
|
|
|
30.
|
|
|
31.
|
|
|
32.
|
|
|
33.
|
|
|
34.
|
|
|
35.
|
|
|
36.
|
|
|
37.
|
Pharmacology and clinical studies with RU 23908 (Anandron). [electronic resource] by
- Raynaud, J P
- Moguilewsky, M
- Tournemine, C
- Pottier, J
- Coussedière, D
- Salmon, J
- Husson, J M
- Bertagna, C
- Tremblay, D
- Pendyala, L
Producer: 19851011
In:
Progress in clinical and biological research vol. 185A
Availability: No items available.
|
|
38.
|
Prevention of the transient adverse effects of a gonadotropin-releasing hormone analogue (buserelin) in metastatic prostatic carcinoma by administration of an antiandrogen (nilutamide). [electronic resource] by
- Kuhn, J M
- Billebaud, T
- Navratil, H
- Moulonguet, A
- Fiet, J
- Grise, P
- Louis, J F
- Costa, P
- Husson, J M
- Dahan, R
Producer: 19890921
In:
The New England journal of medicine vol. 321
Availability: No items available.
|
|
39.
|
New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens. [electronic resource] by
- Labrie, F
- Dupont, A
- Belanger, A
- Lacoursiere, Y
- Raynaud, J P
- Husson, J M
- Gareau, J
- Fazekas, A T
- Sandow, J
- Monfette, G
Producer: 19831217
In:
The Prostate vol. 4
Availability: No items available.
|
|
40.
|
Effects of RU16117, an orally active weak oestrogenic compound, in postmenopausal women. [electronic resource] by
- Faure, N
- Labrie, F
- Olivier, G
- Tremblay, M
- Cloutier, D
- Lemay, A
- Ferland, L
- Azadian-Boulanger, G
- Bouton, M M
- Husson, J M
- Raynaud, J P
Producer: 19810513
In:
Maturitas vol. 2
Availability: No items available.
|